Use of Peptides for the Management of Alzheimer’s Disease: Diagnosis and Inhibition

Alzheimer’s disease (AD) is a form of dementia and the most common progressive neurodegenerative disease (ND). The targeting of amyloid-beta (Aβ) aggregation is one of the most widely used strategies to manage AD, and efforts are being made globally to develop peptide-based compounds for the early d...

Descripción completa

Detalles Bibliográficos
Autores principales: Baig, Mohammad H., Ahmad, Khurshid, Rabbani, Gulam, Choi, Inho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5808296/
https://www.ncbi.nlm.nih.gov/pubmed/29467644
http://dx.doi.org/10.3389/fnagi.2018.00021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5808296/
https://www.ncbi.nlm.nih.gov/pubmed/29467644
http://dx.doi.org/10.3389/fnagi.2018.00021

Ejemplares similares